Cingulate Inc. Shareholders' Equity
Cingulate Inc. (CING) had Shareholders' Equity of $23.47 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-13
- 2026-06-30: Stockholders' Equity Attributable to Parent $23.47M.
- 2026-03-31: Stockholders' Equity Attributable to Parent $18.86M.
- 2025-12-31: Stockholders' Equity Attributable to Parent $2.51M.
- 2025-09-30: Stockholders' Equity Attributable to Parent $3.47M.
| Period end | Stockholders' Equity Attributable to Parent |
|---|---|
| 2026-06-30 | $23.47M 10-Q · filed 2026-08-13 |
| 2026-03-31 | $18.86M 10-Q · filed 2026-08-13 |
| 2025-12-31 | $2.51M 10-Q · filed 2026-08-13 |
| 2025-09-30 | $3.47M 10-Q · filed 2025-11-13 |
| 2025-06-30 | $5.51M 10-Q · filed 2026-08-13 |
| 2025-03-31 | $5.93M 10-Q · filed 2026-08-13 |
| 2024-12-31 | $7.46M 10-Q · filed 2026-08-13 |
| 2024-09-30 | $12.04M 10-Q · filed 2025-11-13 |
| 2024-06-30 | $3.08M 10-Q · filed 2025-11-13 |
| 2024-03-31 | $3.22M 10-Q · filed 2025-11-13 |
| 2023-12-31 | -$6.87M 10-K · filed 2026-03-18 |
| 2023-09-30 | -$96.33K 10-Q · filed 2024-11-07 |
| 2023-06-30 | -$6.10M 10-Q · filed 2024-11-07 |
| 2023-03-31 | $81.61K 10-Q · filed 2024-11-07 |
| 2022-12-31 | $3.88M 10-K · filed 2025-03-27 |
| 2022-09-30 | $8.37M 10-Q · filed 2023-11-13 |
| 2022-06-30 | $12.18M 10-Q · filed 2023-11-13 |
| 2022-03-31 | $16.02M 10-Q · filed 2023-11-13 |
| 2021-12-31 | $20.84M 10-K · filed 2024-04-01 |
| 2021-09-30 | $3.08M 10-Q · filed 2022-11-14 |
| 2021-06-30 | $1.90M 10-Q · filed 2022-11-14 |
| 2021-03-31 | $1.34M 10-Q · filed 2022-11-14 |
| 2020-12-31 | $1.29M 10-K · filed 2023-03-10 |
| 2019-12-31 | $615.88K 10-K · filed 2022-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |